Sale!
PRESTALIA Drug Profile, 2024

PRESTALIA Drug Profile, 2024

Original price was: $800.00.Current price is: $399.00.

PRESTALIA (amlodipine besylate; perindopril arginine) drug patents, patent challenges, litigation, SPCs, API sources

SKU: PRESTALIA Category:
Originally published at https://www.chemintel360.com/. Get our excipient business reports at https://chemintel360.com/product-category/excipients/, and our drug patent reports at https://chemintel360.com/product-category/drug-patent-reports/

PRESTALIA Drug Profile, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

This definitive guide provides invaluable business insights into every crucial aspect of this medication, addressing the vital points necessary to make business decisions.

Gain key critical insights for PRESTALIA:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Raw active pharmaceutical ingredient (API) sources
Pages

20
Product

PRESTALIA

Related products

ChemIntel360
Scroll to Top